Soluble MICA and a MICA Variation as Possible Prognostic Biomarkers for HBV-Induced Hepatocellular Carcinoma

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Kumar, Vinod ^a,b   Yi Lo, Paulisally Hau ^a   Sawai, Hiromi ^c   Kato, Naoya ^a   Takahashi, Atsushi ^b   Deng, Zhenzhong ^a   Urabe, Yuji ^a   Mbarek, Hamdi ^a   Tokunaga, Katsushi ^c   Tanaka, Yasuhito ^d   Sugiyama, Masaya ^e   Mizokami, Masashi ^e   Muroyama, Ryosuke ^a   Tateishi, Ryosuke ^c   Omata, Masao ^c   Koike, Kazuhiko ^c   Tanikawa, Chizu ^a   Kamatani, Naoyuki ^b   Kubo, Michiaki ^b   Nakamura, Yusuke ^a   Matsuda, Koichi ^a   more..

^a UNIVERSITY OF TOKYO   (Japan)

^b INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MAJOR HISTOCOMPATIBILITY ANTIGEN; MHC CLASS I POLYPEPTIDE RELATED CHAIN A; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HEPATITIS B; HIGH RISK PATIENT; HUMAN; INFECTION RISK; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICA GENE; NONHUMAN; PROGNOSIS; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B VIRUS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MINISATELLITE REPEATS; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84866385963     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0044743     Document Type: Article

References (36)

1. Kew MC, (2010) Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol (Paris) 58: 273-277.
2. Sherman M, (2010) Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 30: 3-16.
3. Perz J, Armstrong G, Farrington L, Hutin Y, Bell B, (2006) The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45: 529-538.
4. Chen CJ, Chen DS, (2002) Interaction of hepatitis B virus, chemical carcinogen, and genetic susceptibility: multistage hepatocarcinogenesis with multifactorial etiology. Hepatology 36: 1046-1049.
5. Cui R, Okada Y, Jang SG, Ku JL, Park JG, et al. (2011) Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population. Gut 60: 799-805.
6. Kumar V, Matsuo K, Takahashi A, Hosono N, Tsunoda T, et al. (2011) Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. J Hum Genet England pp. 436-439.
7. Cui R, Kamatani Y, Takahashi A, Usami M, Hosono N, et al. (2009) Functional variants in ADH1B and ALDH2 coupled with alcohol and smoking synergistically enhance esophageal cancer risk. Gastroenterology 137: 1768-1775.
8. Urabe Y, Tanikawa C, Takahashi A, Okada Y, Morizono T, et al. (2012) A genome-wide association study of nephrolithiasis in the Japanese population identifies novel susceptible loci at 5q35.3, 7p14.3 and 13q14.1. PLOS Genet 8 (3):: e1002541.
9. Tanikawa C, Urabe Y, Matsuo K, Kubo M, Takahashi A, et al. (2012) A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nat Genet 44 (4):: 430-434.
10. Hata J, Matsuda K, Ninomiya T, Yonemoto K, Matsushita T, et al. (2007) Functional SNP in an Sp1-binding site of AGTRL1 gene is associated with susceptibility to brain infarction. Hum Mol Genet 16: 630-639.
11. Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, et al. (2009) A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet 41: 591-595.
12. Mbarek H, Ochi H, Urabe Y, Kumar V, Kubo M, et al. (2011) A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Human Molecular Genetics 20: 3884-3892.
13. Zhang H, Zhai Y, Hu Z, Wu C, Qian J, et al. (2010) Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat Genet 42: 755-758.
14. Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, et al. (2011) Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nature genetics 43: 455-458.
15. Jinushi M, Takehara T, Tatsumi T, Kanto T, Groh V, et al. (2003) Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 104: 354-361.
16. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, et al. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285: 727-729.
17. Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, et al. (2006) Soluble MICA in malignant diseases. Int J Cancer 118: 684-687.
18. Nückel H, Switala M, Sellmann L, Horn PA, Dürig J, et al. (2010) The prognostic significance of soluble NKG2D ligands in B-cell chronic lymphocytic leukemia. Leukemia 24: 1152-1159.
19. Tamaki S, Sanefuzi N, Kawakami M, Aoki K, Imai Y, et al. (2008) Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol 69: 88-93.
20. Li K, Mandai M, Hamanishi J, Matsumura N, Suzuki A, et al. (2009) Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis. Cancer Immunol Immunother 58: 641-652.
21. Salih H, Rammensee H, Steinle A, (2002) Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 169: 4098-4102.
22. Groh V, Wu J, Yee C, Spies T, (2002) Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419: 734-738.
23. Jinushi M, Takehara T, Tatsumi T, Hiramatsu N, Sakamori R, et al. (2005) Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J Hepatol 43: 1013-1020.
24. Nakamura Y, (2007) The BioBank Japan Project. Clin Adv Hematol Oncol 5: 696-697.
25. Ota M, Katsuyama Y, Mizuki N, Ando H, Furihata K, et al. (1997) Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 49: 448-454.
26. Tamaki S, Sanefuzi N, Ohgi K, Imai Y, Kawakami M, et al. (2007) An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients. J Oral Pathol Med 36: 351-356.
27. Tamaki S, Kawakami M, Yamanaka Y, Shimomura H, Imai Y, et al. (2009) Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Clin Immunol 130: 331-337.
28. Lü M, Xia B, Ge L, Li Y, Zhao J, et al. (2009) Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients. Immunology 128: e230-236.
29. Bonilla Guerrero R, Roberts LR, (2005) The role of hepatitis B virus integrations in the pathogenesis of human hepatocellular carcinoma. J Hepatol 42: 760-777.
30. Bouchard MJ, Schneider RJ, (2004) The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734.
31. Groh V, Bahram S, Bauer S, Herman A, Beauchamp M, et al. (1996) Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A 93: 12445-12450.
32. Groh V, Steinle A, Bauer S, Spies T, (1998) Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 279: 1737-1740.
33. Groh V, Rhinehart R, Randolph-Habecker J, Topp M, Riddell S, et al. (2001) Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat Immunol 2: 255-260.
34. Gasser S, Orsulic S, Brown EJ, Raulet DH, (2005) The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436: 1186-1190.
35. Lara-Pezzi E, Gomez-Gaviro MV, Galvez BG, Mira E, Iniguez MA, et al. (2002) The hepatitis B virus X protein promotes tumor cell invasion by inducing membrane-type matrix metalloproteinase-1 and cyclooxygenase-2 expression. J Clin Invest 110: 1831-1838.
36. Jinushi M, Hodi F, Dranoff G, (2006) Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc Natl Acad Sci U S A 103: 9190-9195.